En annan verklighet

: En allmän litteraturstudie om personers upplevelser av läkemedelsbehandling med neuroleptika vid schizofreni

Abstract

Backgroud: Schizophrenia is a chronic and severe psychosis. A person that
becomes ill in schizophrenia will be needing long-term support from healthcare.
To provide care and support in schizophrenia, the Swedish Board of Health and
Welfare has formulated national guidelines, which include early introduction of
neuroleptics. People with schizophrenia have a reduced ability to give their
consent to the treatment, which threatens autonomy and dignity. It is important
that health care enables participation and provides equal care in order to
compensate for the lost autonomy. Aim: The aim was to describe people’s
experience of drug treatment with neuroleptics in schizophrenia. Method: This is
a literature study based on ten qualitative articles. Cinahl Complete, PubMed and
PsycINFO were used as databases. Results: The results show that the majority of
participants experienced reduced autonomy and participation. The relationship
between health care professionals proved to be important for successful treatment. People experienced a fear of stigma and that they do not want to be associated as mentally ill or crazy. Long-acting injections promote autonomy and participation so that the participants can focus on recovering and not feel locked up. Discussion: Using the concepts of credibility, dependability, confirmability and transferability, the method of this study has been discussed. Strengths and
weaknesses have been highlighted. The discussion of results highlights three main findings that were categorized as: the pursuit of participation, fear of
stigmatization and long-acting injections promote well-being. Discussion based
on ethics and person-centered care is carried out together with nursing theoretical foundations.

Date of Award	2021-Dec
Original language	Swedish
Supervisor	Cecilia Gardsten (Supervisor) & Susanne Lindskov (Examiner)